362 related articles for article (PubMed ID: 29259102)
1. Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD mice.
Dwyer CJ; Bayer AL; Fotino C; Yu L; Cabello-Kindelan C; Ward NC; Toomer KH; Chen Z; Malek TR
Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259102
[TBL] [Abstract][Full Text] [Related]
2. IL-2Rβ-dependent signaling and CD103 functionally cooperate to maintain tolerance in the gut mucosa.
Yuan X; Dee MJ; Altman NH; Malek TR
J Immunol; 2015 Feb; 194(3):1334-46. PubMed ID: 25527788
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
[TBL] [Abstract][Full Text] [Related]
4. The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid Mice.
Presa M; Chen YG; Grier AE; Leiter EH; Brehm MA; Greiner DL; Shultz LD; Serreze DV
J Immunol; 2015 Oct; 195(7):3011-9. PubMed ID: 26283479
[TBL] [Abstract][Full Text] [Related]
5. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
6. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
7. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
9. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-β7-dependent localization.
Li CR; Deiro MF; Godebu E; Bradley LM
J Autoimmun; 2011 Nov; 37(3):217-27. PubMed ID: 21745722
[TBL] [Abstract][Full Text] [Related]
10. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091
[TBL] [Abstract][Full Text] [Related]
11. IL-15 promotes regulatory T cell function and protects against diabetes development in NK-depleted NOD mice.
Xia J; Liu W; Hu B; Tian Z; Yang Y
Clin Immunol; 2010 Feb; 134(2):130-9. PubMed ID: 19875339
[TBL] [Abstract][Full Text] [Related]
12. Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice.
Kaminitz A; Mizrahi K; Ash S; Ben-Nun A; Askenasy N
Immunology; 2014 Jul; 142(3):465-73. PubMed ID: 24601987
[TBL] [Abstract][Full Text] [Related]
13. IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development.
Cheng G; Yu A; Dee MJ; Malek TR
J Immunol; 2013 Feb; 190(4):1567-75. PubMed ID: 23315074
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.
Tonkin DR; He J; Barbour G; Haskins K
J Immunol; 2008 Oct; 181(7):4516-22. PubMed ID: 18802054
[TBL] [Abstract][Full Text] [Related]
16. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice.
Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R
Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888
[TBL] [Abstract][Full Text] [Related]
17. The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.
Kachapati K; Adams DE; Wu Y; Steward CA; Rainbow DB; Wicker LS; Mittler RS; Ridgway WM
J Immunol; 2012 Nov; 189(10):5001-15. PubMed ID: 23066155
[TBL] [Abstract][Full Text] [Related]
18. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
Manirarora JN; Wei CH
J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
[TBL] [Abstract][Full Text] [Related]
19. Targeting CD44 augments the efficacy of Tregs in autoimmune diabetes.
Li CR; Mueller EE; Bradley LM
Immunol Lett; 2015 Feb; 163(2):199-205. PubMed ID: 25447401
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]